PUBLISHER: The Business Research Company | PRODUCT CODE: 1946993
PUBLISHER: The Business Research Company | PRODUCT CODE: 1946993
Polymethyl methacrylate (PMMA) bone cement is a synthetic material used in orthopedic surgeries to secure implants and fill gaps within bones. It serves as a bonding material between implants and bone, providing stability and is widely used in joint replacements due to its strong adhesive capabilities and biocompatibility.
The principal types of polymethyl methacrylate (PMMA) bone cement include low-viscosity cement, medium-viscosity cement, and high-viscosity cement. Low-viscosity bone cements are defined by their thin and fluid consistency, enabling easy flow into small or complex bone cavities. These cements are applied in joint procedures, vertebral treatments, and others and are used by end users including hospitals, ambulatory surgical centers, and orthopedic clinics.
Tariffs have moderately increased the costs of imported polymers, monomers, and specialty additives used in pmma bone cement production, leading to higher input prices and margin pressure across the market. These cost impacts are most visible in high viscosity and medium viscosity cement segments used in joint and vertebral applications, particularly in Europe and Asia where a significant share of raw materials is sourced internationally. Manufacturers in these regions are facing supply chain complexity and cost volatility, which can affect pricing and procurement strategies for hospitals and orthopedic clinics. However, tariffs have also supported local cement production by encouraging regional sourcing of pmma resins and fillers, driving investments in formulation efficiency and domestic manufacturing capacity, which is improving supply security and long-term cost stability.
The polymethyl methacrylate (pmma) bone cements market research report is one of a series of new reports from The Business Research Company that provides polymethyl methacrylate (pmma) bone cements market statistics, including polymethyl methacrylate (pmma) bone cements industry global market size, regional shares, competitors with a polymethyl methacrylate (pmma) bone cements market share, detailed polymethyl methacrylate (pmma) bone cements market segments, market trends and opportunities, and any further data you may need to thrive in the polymethyl methacrylate (pmma) bone cements industry. This polymethyl methacrylate (pmma) bone cements market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The polymethyl methacrylate (pmma) bone cements market size has grown strongly in recent years. It will grow from $1.25 billion in 2025 to $1.34 billion in 2026 at a compound annual growth rate (CAGR) of 6.9%. The growth in the historic period can be attributed to aging population growth, increased orthopedic procedures, rising osteoarthritis prevalence, expansion of hospital infrastructure, demand for implant stability.
The polymethyl methacrylate (pmma) bone cements market size is expected to see strong growth in the next few years. It will grow to $1.73 billion in 2030 at a compound annual growth rate (CAGR) of 6.6%. The growth in the forecast period can be attributed to growth in minimally invasive surgeries, increasing sports injuries, expansion of ambulatory surgery centers, demand for faster recovery solutions, innovation in cement formulations. Major trends in the forecast period include rising joint replacement surgeries, growing demand for high-viscosity cements, expansion of vertebral repair procedures, increased adoption in trauma surgeries, improvements in cement handling properties.
The rise in sports-related injuries is increasingly supporting the expansion of the polymethyl methacrylate bone cement market going forward. Sports-related injuries involve physical damage sustained during athletic or exercise activities and are becoming more common due to increased participation in high-intensity sports, insufficient training, and inadequate injury prevention practices. Polymethyl methacrylate bone cement is extensively used in orthopedic procedures to manage sports-related injuries by providing structural support and stability to fractured or damaged bones. It facilitates secure implant fixation during joint replacement and fracture repair surgeries. For example, according to Injury Facts published by the National Safety Council, a US-based nonprofit organization, exercise and exercise equipment-related injuries increased by 8% to 482,886 cases in 2023, up from 445,642 cases in 2022. As a result, the growing incidence of sports-related injuries is contributing to the expansion of the PMMA bone cement market.
Leading companies operating in the polymethylmethacrylate (PMMA) bone cement market are focusing on innovative solutions, such as antibiotic-loaded bone cement, to support the treatment of periprosthetic joint infections. Antibiotic-loaded bone cement is a specialized orthopedic material infused with antibiotics to prevent and treat infections during joint replacement and other orthopedic procedures. For example, in August 2024, Heraeus Medical GmbH, a Germany-based medical technology manufacturer, launched COPAL G+V Dual Antibiotic-Loaded Bone Cement. This product combines gentamicin and vancomycin to deliver broad-spectrum antimicrobial coverage and is designed to reduce infection risk in high-risk orthopedic surgeries by enabling targeted antibiotic release and improved postoperative outcomes.
In July 2024, Tecres, an Italy-based manufacturer of PMMA bone cement, partnered with Wiltrom. Through this collaboration, Wiltrom aims to expand into the European market, with Tecres distributing Wiltrom's Tripod-Fix Vertebral Body Augmentation System across multiple countries, including Spain, Poland, and Switzerland, thereby expanding product availability for percutaneous vertebroplasty procedures. Wiltrom is a US-based company specializing in spinal and interbody fixation systems.
Major companies operating in the polymethyl methacrylate (pmma) bone cements market are Stryker Corporation, Zimmer Biomet Holdings Inc., Heraeus Medical GmbH, Exactech Inc., Mathys AG Bettlach, Aap Implantate AG, Cambridge Polymer Group Inc., Teknimed SA, Tecres S.p.A., BioMedtrix LLC, Smith & Nephew plc, G21 srl, Graftys, Noblus, B Braun Melsungen AG, DJO Global Inc, Aegis Spine Inc, Alphatec Spine Inc, Cook Medical Inc, Elite Surgical, Evolutis, Meril Life Sciences Private Limited, Tecomet Inc, Merete Medical GmbH, Solco Biomedical, Orthoplastics, Medacta International, Somatex Medical Technologies
North America was the largest region in the polymethyl methacrylate (PMMA) bone cement market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the polymethyl methacrylate (pmma) bone cements market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
The countries covered in the polymethyl methacrylate (pmma) bone cements market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain
The polymethyl methacrylate (PMMA) bone cement market consists of sales of standard PMMA bone cement, antibiotic-loaded PMMA bone cement, and fast-setting PMMA bone cement. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Polymethyl Methacrylate (PMMA) Bone Cements Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses polymethyl methacrylate (pmma) bone cements market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Where is the largest and fastest growing market for polymethyl methacrylate (pmma) bone cements ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The polymethyl methacrylate (pmma) bone cements market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.